Mannose-capped lipoarabinomannan (ManLAM) is an immunomodulatory epitope of Mycobacterium tuberculosis (Mtb). An aptamer (ZXL1) that specifically binds to ManLAM from the virulent Mtb H37Rv strain was previously generated and it was found that ZXL1 functions as an antagonist, inhibiting the ManLAM-induced immunosuppression of DCs. In the present study, it was found that ZXL1 inhibits Mtb entry into murine macrophages and that ZXL1 enhances IL-1b and IL-12 mRNA expression and cytokine production in ManLAM-treated macrophages but decreases IL-10 production. Inducible nitric oxide synthase expression in macrophages was upregulated in the presence of ZXL1 after stimulation with ManLAM. ZXL1 was also found to inhibit expression of lipid-sensing nuclear receptor peroxisome proliferator-activated receptor g (PPAR-g). These results suggest that ZXL1 promotes anti-tuberculosis activity through downregulation of PPAR-g expression, which may contribute to M1 macrophage polarization and Mtb killing by macrophages.
inflammation and lipid metabolism (8, 9) . PPAR-g is highly expressed in M2 macrophages (6) and acts as a negative regulator of macrophage activation by modulating inflammatory gene expression (10, 11) , regulating macrophage differentiation and activation (12) and attenuating respiratory bursts (13) .
The complex outermost components of the mycobacterial cell wall, which is composed predominantly of lipids and carbohydrates, are the first to contact host cellular constituents and therefore play a major role in facilitating host cell entry and modulating host cell responses. ManLAM, an immunomodulatory epitope on the surface of Mtb, induces IL-10 but downregulates IL-12 and TNF-a production by macrophages (14, 15) . ManLAM also suppresses macrophage apoptosis induced by Mtb infection, which may facilitate Mtb survival in the cells (16) .
Aptamers are short, structured, single-stranded RNA or DNA ligands that bind to specific target molecules. Aptamers are selected by performing an in vitro selection process called Systematic Evolution of Ligands by EXponential enrichment (acronym SELEX) (17, 18) . Because of their high affinity and specificity, aptamers have been used as therapeutic or diagnostic tools in numerous investigations (19, 20) . In our previous studies, we generated the ssDNA aptamer ZXL1 specifically against ManLAM from virulent Mtb H37Rv and the ssDNA aptamer BM2, which specifically binds to ManLAM from Mycobacterium bovis (termed BCG), based on the different structures of ManLAMs in different Mycobacteria (21, 22) . We reported that ZXL1 competes with the MR for binding to ManLAM and inhibits ManLAM-induced immunosuppression of DCs and that BM2 promotes M1 macrophage polarization (21, 22) . However, we do not know the effects of ZXL1 on macrophages or the exact nature of the cellular signaling pathway triggered by anti-ManLAM aptamers. In the present study, we found that ZXL1 inhibits phagocytosis of virulent Mtb by macrophages, enhances IL-1b and IL-12 production, decreases IL-10 production and upregulates iNOS expression associated with downregulated expression of PPARg.
MATERIALS AND METHODS

Bacterial strains and cells
Mtb H37Rv (American Type Culture Collection (ATCC) strain 93009) was purchased from the Beijing Biological Product Institute (Beijing, China). Mtb H37Rv was maintained on Lowenstein-Jensen medium and harvested while in the log phase of growth. Bacilli were washed in PBS containing 0.05% Tween-80 and triturated uniformly before use (23) . The murine macrophage cell line RAW264.7 was purchased from the China Center for Type Culture Collection (Wuhan, China).
ManLAM preparation
ManLAM was extracted and purified from delipidated cells as previously described (21, 24) . Briefly, Mtb H37Rv cells were collected and directly delipidated using CHCl 3 : CH 3 OH (2:1, v/v) at 37°C for 12 hr followed by CHCl 3 : CH 3 OH:H 2 O (10:10:3, v/v/v) for an additional 12 hr. The lipid extracts were further precipitated using cold acetone for 24 hr at À20°C. Pellets containing a mixture of phospholipids were dried and suspended in breaking buffer containing a protease inhibitor mixture (pepstatin A, PMSF, and leupeptin), DNase, and RNase in PBS and lysed with an ultrasonic disruptor. Triton X-114 (8% v/v; Sigma-Aldrich, St Louis, MO, USA) was added to the lysed cells and the solution mixed at 4°C overnight. After centrifugation at 27,000 g for 1 hr at 4°C, the cell walls were removed and the supernatant incubated at 37°C to induce biphasic separation. The upper aqueous layer was mixed with the cellular debris and re-extracted as described above. The lipoglycans in the detergent layers were precipitated by the addition of nine volumes of cold ethanol (95%, À20°C). The precipitates were collected and treated with proteinase K for 2 hr at 60°C. The resultant solution containing ManLAM and lipomannan was dialyzed and lyophilized. To purify ManLAM, HPLC was performed on an Agilent liquid chromatography system (Santa Clara, CA, USA) fitted with a Sephadex column (GE Healthcare, Little Chalfont, UK) equilibrated with 0.2 M NaCl, 0.25% deoxycholate, 1 mM EDTA, 0.02% sodium azide and 10 mM Tris (pH 8.0) at a flow rate of 1 mL/min. SDS-PAGE and periodic acid-silver staining were used to monitor the elution profile of the fractions containing ManLAM.
Flow cytometry to identify bacteria in macrophages
Mouse peritoneal macrophages were isolated from BALB/c mice by washing their peritoneal cavities with 5 mL of ice-cold PBS. The cells were centrifuged (300 g; 5 min), resuspended in complete RPMI 1640, adjusted to 2 Â 10 6 cells/mL and cultured in 6-well plates for 2 hr. Non-adherent cells were removed by washing with PBS. The adhered macrophages were cultured with rhodamine B-labeled iH37Rv at a ratio of 10:1 (bacteria: cells) in the presence of ZXL1 (0.2, 1 and 5 mm) for 3 hr. After removing extracellular bacteria by washing, the macrophages were washed twice with 0.05% EDTA in free serum medium so that non-adherent cells could be removed for FCM analysis (C6 Flow Cytometer System, BD Biosciences, New Jersey, USA).
qRT-PCR
The adhered macrophages (2 Â 10 6 cells/mL) were cultured with iH37Rv (2 Â 10 7 bacilli/mL)/ManLAM (5 mg/mL) in the presence of ZXL1 (5 mM) for 12 hr. Total RNA was extracted from the cells using TRIzol Reagent (Life Technologies, Carlsbad, CA, USA). A ReverTra Ace-a-First Strand cDNA Synthesis Kit (Toyobo Biologics, Osaka, Japan) was used according to the manufacturer's instructions to synthesize first strand cDNA from the mRNA in the total RNA sample. The resulting cDNA was stored at À20°C until use in qRT-PCR experiments.
Quantitative PCR was performed on an ABI Prism StepOnePlus real-time PCR System (Applied Biosystems, Foster, CA, USA). The assays were performed for quantification of IL-1b, IL-12, IL-10, TGF-b, iNOS and Arg-1 using a SYBR Green real-time PCR Master Mix kit 
ELISA
The adhered macrophages (2 Â 10 6 cells/mL) were cultured with iH37Rv (2 Â 10 7 bacilli/mL)/ManLAM (5 mg/mL) in the presence of ZXL1 (5 mM) for 12 hr. The cells were then washed three times to remove iH37Rv/ManLAM and aptamers, after which they were further cultured for 48 hr or 96 hr. The cell culture supernatants were collected and the cytokines determined by ELISA (Dakewe Biotech, Shenzhen, China).
NO assay
The adhered macrophages (2 Â 10 6 cells/mL) were cultured with iH37Rv (2 Â 10 7 bacilli/mL)/ManLAM (5 mg/mL) in the presence of ZXL1 (5 mM) for 12 hr and then were washed three times to remove iH37Rv/ ManLAM and aptamers. Then the cells were further cultured for 24 hr. The supernatants (50 mL) were harvested and mixed with 50 mL of Griess reagent I and 50 mL of Griess reagent II (Beyotime Biotech, Jiangsu, China) (25) . The nitrite concentration was determined by spectrophotometry (560 nm) according to the protocol recommended by the manufacturer. NO data are expressed as the mean AE SD (nitrite) in mM.
Enzyme-linked oligonucleotide assay
Enzyme-linked oligonucleotide assays were performed according to our previous report (21, 22) . ELISA plates were coated with ManLAM (1 mg/mL) overnight at 4°C. After blocking with 200 mL salmon sperm DNA (100 mg/ mL) at 37°C for 1 hr, biotin-labeled ZXL1 (2 mM) were added and incubated in the presence of MR (400 nM) or Dectin-2 protein (400 nM) at 37°C for 2 hr. HRPconjugated streptavidin (1:4000) was then added and incubated for 30 min at 37°C. After adding substrate and stop buffer, absorbance was determined at 450 nm by using a microplate reader. As a background control, ManLAM alone was coated on the wells but no aptamer ZXL1 was added. For each sample, the OD 450 value of the background control was subtracted from the OD 450 value of the experimental sample. Washes were performed to remove unbound aptamers in the enzyme-linked oligonucleotide assay.
Western blot
The adhered macrophages (2 Â 10 6 cells/mL) were cultured with iH37Rv (2 Â 10 7 bacilli/mL)/ManLAM (5 mg/mL) in the presence of ZXL1 (5 mM) and then lysed with RIPA lysis buffer (Thermo Scientific, Waltman, WY, USA) and centrifuged to remove cell debris. The supernatants were subjected to SDS-PAGE, after which the proteins were transferred to polyvinylidene fluoride membranes. The membranes were then incubated with 2% BSA in TBST, and then with the indicated primary antibodies and HRP-conjugated secondary antibodies. Anti-iNOS mAbs were obtained from Abcam (Cambridge, UK). Anti-Arg-1 mAbs and Anti-PPAR-g polyclonal antibodies were purchased from Cell Signaling (Beverly, MA, USA). HRP-conjugated secondary antibodies were purchased from Affinity Biosciences (Beverly, MA, USA). Chemiluminescent detection was performed by using ECL Plus western blotting reagents (Thermo Scientific). Quantification was performed using NIH ImageJ software.
Statistical analysis
Quantitative data are presented as means AE SD. Statistical analysis was determined by Student's t-test or anova followed by Neuman-Keuls post hoc test. In every analysis values of P < 0.05 were considered to denote significance.
RESULTS
ZXL1 inhibits Mtb entry into macrophages
We have reported that ZXL1 targets Mtb ManLAM and interferes with binding of MR to Mtb (21). Because binding of MR to Mtb induces phagocytosis by macrophages (26), we evaluated whether ZXL1 blocks Mtb entry. As shown in Figure 1 , we incubated iH37Rv with murine peritoneal macrophages in the presence of ZXL1 and then evaluated the attached to/engulfed bacteria with FCM. Our data showed that ZXL1 inhibits iH37Rv entry into macrophages (Fig. 1) . The percentage inhibition increased in parallel with increased concentrations of ZXL1. After treatment with 5 mM ZXL1, the percentage of macrophages taking up iH37Rv dropped from 15.9% to 7.2%, indicating that ZXL1 prevented more than half the Mtb from entering (Fig. 1) . Here, we used ZXL4 as an aptamer control (21) . ZXL4 slightly inhibited phagocytosis, likely because ZXL4 may bind nonspecifically to iH37Rv (Fig. 1) .
ZXL1 enhances IL-1b and IL-12p40 mRNA expression but decreases IL-10 mRNA expression in macrophages upon stimulation with ManLAM
To assess the production of cytokines induced by iH37Rv/ManLAM in macrophages in the presence of ZXL1, we quantified mRNA expression of IL-1b, IL-12p40, IL-10 and TGF-b by qRT-PCR analysis. As shown in Figure 2a and b, after stimulation with ManLAM/iH37Rv þ ZXL1, mRNA expression of IL-1b and IL-12p40 (second and fifth columns from left to right in Fig. 2a,b) in macrophages was significantly greater than that of the ManLAM/iH37Rv control group (first and fourth columns from left to right). Addition of ZXL4 slightly enhanced mRNA expression of IL-1b and IL-12p40 in macrophages stimulated with ManLAM/ iH37Rv (third and sixth columns from left to right in Fig. 2a,b) . This likely was caused by nonspecific binding of ZXL4 to ManLAM/iH37Rv. The strength of mRNA expression did not change when we simulated the macrophages with ZXL1 or ZXL4 alone (seventh and eighth columns from left to right in Fig. 2a,b) , indicating that the ssDNA aptamer alone does not enhance mRNA expression.
Addition of ZXL1 significantly reduced mRNA expression of IL-10 in ManLAM-treated macrophages (second column from left to right in Fig. 2c ), whereas addition of ZXL1 did not significantly change mRNA expression of IL-10 in iH37Rv-treated macrophages (fifth column from left to right in Fig. 2c ). There were no significant differences in mRNA expression of TGF-b between the ManLAM/iH37Rv þ ZXL1 and ManLAM/ iH37Rv groups (Fig. 2d) . Taken together, our results suggest that ZXL1 enhances IL-12p40 and IL-1b mRNA expression but decreases IL-10 mRNA expression in macrophages upon ManLAM stimulation (Fig. 2a-d) .
ZXL1 enhances IL-1b and IL-12p70 production and decreases IL-10 production in macrophages upon stimulation with ManLAM
To determine cytokine production, we stimulated macrophages with ManLAM/iH37Rv þ ZXL1 for 12 hr, then removed ManLAM/iH37Rv and ZXL1 by washing and further cultured the macrophages for 48 hr or 96 hr. We quantitated concentrations of IL-1b, IL12p70, IL-10 and TGF-b in the supernatant with ELISA. As shown in Figure 3a , stimulation with ManLAM/ iH37Rv did not change IL-1b production in macrophages (first, fourth, 10th and 13th columns from left to right) compared with the normal cell control group (ninth and 18th columns from left to right). Addition of ZXL1 enhanced IL-1b production in both ManLAMand iH37Rv-treated macrophages at 48 hr and 96 hr (second, fifth, 11th and 14th columns from left to right in Fig. 3a) .
Stimulation with ManLAM/iH37Rv resulted in slightly greater production of IL-12p70 (first, fourth, 10th and 13th from left to right in Fig. 3b ) than in the normal cell control group (ninth and 18th columns from left to right in Fig. 3b ). The amount of IL-12p70 produced by ManLAM-treated macrophages increased significantly in the presence of ZXL1 at 96 hr (11th column from left to right in Fig. 3b ). These data show that mRNA expression of IL-12p40 increased significantly in both the ManLAM þ ZXL1 and iH37Rv þ ZXL1 groups (Fig. 2b) . However, there was only a slight increase in IL-12p70 protein production in the iH37Rv þ ZXL1 treatment group (fifth and 14th columns from left to right in Fig. 3b) . These results may indicate that some type of post-translational regulation affected IL12p70 production in the iH37Rv þ ZXL1 group. Moreover, the complex cell walls of Mtb contain peptidoglycan, arabinogalactan, mycolic acid and several types of glycolipids in addition to ManLAM (27) . ZXL1 may bind nonspecifically to some other glycolipids and that nonspecific binding may have complex effects on IL-12 production by Mtb-treated macrophages, which would account for only a slightly enhancement of IL12p70 production in iH37Rv-treated macrophages after adding ZXL1 (Fig. 3b) .
ManLAM caused increased IL-10 production in macrophages at both 48 hr and 96 hr (first and 10th columns from left to right in Fig. 3c ). Addition of ZXL1 significantly decreased IL-10 production by ManLAMtreated macrophages at both 48 hr and 96 hr (second and 11th columns from left to right in Fig. 3c ). IH37Rv increased IL-10 production in macrophages at 96 hr (13th column from left to right in Fig. 3c ). However, addition of ZXL1 did not significantly decrease IL-10 production by iH37Rv-treated macrophages (fifth and 14th columns from left to right in Fig. 3c ). These data are consistent with the mRNA expression of IL-10 in macrophages treated with iH37Rv þ ZXL1 (Fig. 2c ) and indicate that some other components of the complex Mtb cell wall may be involved in induction of IL-10 production in macrophages. ZXL1 had no effect on TGF-b production by macrophages stimulated with ManLAM/iH37Rv (Fig. 3d) . In the presence of ZXL1 or ZXL4 alone, IL-1b production was slightly greater; however, IL-12p70, IL-10 and TGF-b production did not change compared with the normal cell control group (Fig. 3a-d) . The M1 macrophage phenotype is characterized by strong expression of proinflammatory cytokines such as IL-1b and IL-12 (28) . Here, increased IL-1b and IL-12p70 production and decreased IL-10 production in the ManLAM þ ZXL1 group indicates that ZXL1 binding to ManLAM may promote M1 macrophage polarization, which is consistent with our previously reported findings (22) .
ZXL1 binding to ManLAM promotes iNOS expression by macrophages stimulated with ManLAM/iH37Rv
INOS is a hallmark of M1 macrophages, whereas Arg-1 is a hallmark of M2 macrophages (28) . To determine iNOS and Arg-1 expression, we stimulated macrophages with ManLAM/iH37Rv þ ZXL1 for 12 hr and quantitated mRNA expression of iNOS and Arg-1 by qRT-PCR. The stimulated cells were then washed to remove the ManLAM/iH37Rv þ ZXL1 and further cultured for 12 hr, after which we assessed iNOS and Arg-1 expression in the macrophages by western blot. As shown in Figure 4a , after stimulation with ManLAM/iH37Rv þ ZXL1, mRNA expression of iNOS in the macrophages increased significantly (second and fifth columns from left to right in Fig. 4a ), whereas there was no significant change in mRNA expression of Arg-1. Protein expression of iNOS and Arg-1 was consistent with their mRNA expression (Fig. 4b) . In the presence of ZXL1, iNOS protein expression was upregulated in the ManLAM/ iH37Rv þ ZXL1 group compared with the ManLAM/ iH37Rv group; however, there was no significant difference in Arg-1 protein expression between the groups (Fig. 4b) . ZXL1 or ZXL4 alone had no effect on iNOS or Arg-1 expression (Fig. 4a,b) . NO secretion was significantly upregulated in ManLAM/iH37Rv-treated macrophages in the presence of ZXL1 (Fig. 4c) . These data suggest that ZXL1 binding to ManLAM promotes iNOS expression by macrophages stimulated with ManLAM/iH37Rv and promotes macrophage polarization toward the M1 phenotype.
ZXL1 binding to ManLAM downregulates PPAR-g expression by macrophages
Mtb and ManLAM reportedly upregulate PPAR-g expression in macrophages, linking MR recognition to regulation of immune responses (6) . We have also reported that ZXL1 competes with MR for binding to ManLAM (21) . Here, we assessed whether blocking ManLAM binding to macrophages with ZXL1 alters their PPAR-g expression. We stimulated murine peritoneal macrophages with ManLAM/iH37Rv þ ZXL1 for 6 hr or 9 hr, and then determined PPAR-g expression in the cells by western blot. As shown in Figure 5 , addition of ZXL1 significantly decreased PPAR-g expression in ManLAM/ iH37Rv-treated cells. These data indicate that ZXL1 may downregulate PPARg expression by blocking binding of ManLAM to MR on macrophages. 5 . ZXL1 binding to ManLAM downregulates PPAR-g expression by macrophages. Murine peritoneal macrophages were stimulated with ManLAM/iH37Rv þ ZXL1 for 6 hr or 9 hr, after which PPAR-g expression in the cells was quantitated by western blot.
Ã P < 0.05 vs.
ManLAM/iH37Rv or ManLAM/iH37Rv þ ZXL4. All data are shown as mean AE SD (n ¼ 3).
DISCUSSION
Modulation of the host immune response is an essential component of mycobacterial pathogenesis. This bacterium suppresses immune responses in part through its complex cell wall structures, which enhance its survival in macrophages. ManLAM, a major component of Mtb cell walls, interacts with host cell surface receptors, including MR, TLR2 and TLR4, DC-SIGN, sphingosine-1-phosphate receptor 1, CD1d, Dectin-2 and CD44, to mediate immune regulation of immune cells (21, 22, (29) (30) (31) (32) (33) (34) . These interactions between ManLAM and host cell receptors lead to altered cellular signaling and responses. In our previous study, we generated the aptamer ZXL1 specifically against virulent Mtb H37Rv and demonstrated that ZXL1 inhibits interaction between ManLAM and MR in a competitive manner and also inhibits ManLAM-induced immunosuppression of DCs (21) . MR is also primarily present on the surface of macrophages. In the current study, we investigated the anti-TB effects of ZXL1 on macrophages upon Mtb stimulation. Dectin-2 can reportedly recognize high-mannose structures and is a direct receptor for ManLAM of Mycobacteria (34) . Some studies have shown that Dectin-2 binds to high-mannose structures, similar to DC-SIGN, SIGNR1, SIGNR3, and MR (35) , all of which possess carbohydrate recognition domains (36) . We also assessed the effects of ZXL1 on interactions between Dectin-2 and ManLAM. As shown in Figure 6 , our data show that Dectin-2 protein slightly inhibits ZXL1 binding to ManLAM. However, we found that MR inhibits binding of ZXL1 to ManLAM more potently than does Dectin-2 protein (Fig. 6 ). These findings may be attributable to difference in the carbohydrate recognition domain structures of MR and Dectin-2. We plan to examine the effects of ZXL1 on Dectin-2-ManLAM interaction in future studies.
Phagocytosis of Mtb can be mediated by binding of the ManLAM mannose caps of Mtb to MR on macrophages (37) . We have demonstrated that the aptamer ZXL1 binds to the mannan and N-acetyl-D(þ)-glucosamine-rich domain of ManLAM, disrupting the interaction between MR and ManLAM (21) . Here, we evaluated the ZXL1 effects on Mtb entry into macrophages and found that the amount of iH37Rv attached to/engulfed by macrophages gradually decreases as the ZXL1 concentration increases, which indicates that ZXL1 binding to Mtb ManLAM inhibits Mtb entry into macrophages (Fig. 1) .
To assess the ZXL1 effects on cytokine production by ManLAM/Mtb-treated macrophages, we assessed both mRNA expression and cytokine production of IL-1b, IL12p40, IL-10 and TGF-b. M1 macrophages often increase production of inflammatory cytokines such as IL-12 and IL-1b, whereas M2 macrophages often produce the anti-inflammatory cytokine IL-10 and TGF-b (38, 39) . It has been reported that IL-1 and IL-12 confer host resistance to Mtb, whereas IL-10 and TGF-b facilitate Mtb escape from immune attack (40) (41) (42) (43) . Nigou et al. have reported that stimulation with ManLAM through MR on DCs leads to inhibition of IL-12 production (44) . Our data show that ZXL1 binding to ManLAM enhances IL-12p40 and IL-1b but decreases IL-10 at the cytokine mRNA and protein levels in macrophages upon stimulation with ManLAM (Figs.,3 2) , which is consistent with our previous findings (22) . Our present data indicate that ZXL1 binding to ManLAM from virulent Mtb contributes to induction of M1-type cytokine production by macrophages and facilitates anti-TB immune responses in vitro.
INOS is a hallmark of M1 macrophages, and NO produced by iNOS is an important host defense molecule against Mtb in macrophages (28). It has been speculated that recognition of Mtb by MR mayt lead to a latent stage of infection (45) . We found that addition of ZXL1, which blocks ManLAM binding to MR, increases iNOS production by ManLAM-treated macrophages to approximately two-fold that induced by ManLAM treatment alone (Fig. 4b) . These findings suggest that recognition of ManLAM by MR is involved in downregulation of iNOS production. Moreover, ManLAM resulted in slightly greater iNOS production than in the normal cell control group (Fig. 4a,b) , probably because ManLAM can be recognized by several types of receptors on macrophages (including MR, TLR2, TLR4, DC-SIGN, sphingosine-1-phosphate receptor 1, CD1d, Dectin-2 and CD44) (21, 22, (29) (30) (31) (32) (33) (34) . Interactions between ManLAM and these receptors may lead to activation of different signaling pathways, resulting in production of small amounts of iNOS.
Although the cytoplasmic domain of MR does not contain any signaling motifs, MR has been shown to participate in intracellular signaling leading to target gene expression (6, 46, 47) . It has been proven that MR has to be assisted by TLR2 to trigger a signaling cascade (46, 47) . TLR2 also has been shown to recognize ManLAM (30) . Therefore, we predict that MR cooperates with TLR2 or other cell surface receptors for recognition of ManLAM and activation of intracellular signaling cascade. The cooperating receptors and intracellular signaling pathways will be determined in future studies.
We have also reported that BM2 enhances iNOS expression and promotes M1 polarization of macrophages upon BCG/BCG ManLAM stimulation (22) . However, the intracellular signaling pathway involved in aptamer-increased iNOS production and M1 macrophage polarization has not been completely investigated. Activation of PPAR-g, a key transcription factor in M2 macrophage polarization (48) , is associated with suppression of iNOS expression and upregulation of IL-10 production (12, 49). Rajaram et al. found that ManLAM binding to MR on macrophages is involved in upregulation of PPAR-g expression (6) . Here, we used the aptamer ZXL1 to block binding of ManLAM to MR and found that addition of ZXL1 enhances iNOS expression and downregulates PPAR-g expression in macrophages. Therefore, we propose a model (Fig. 7) whereby ZXL1 blocks recognition of virulent Mtb and ManLAM by MR, which in turn leads to downregulation of PPAR-g expression and activation, increased iNOS induction, enhanced IL-1b and IL-12 production and reduced IL-10 production, which may contribute to M1 macrophage polarization and Mtb killing by the macrophages.
In our previous study, we demonstrated that ZXL1 blocks ManLAM-induced immunosuppression of DCs and validated the anti-TB effects of ZXL1 in mice and rhesus monkeys challenged with virulent Mtb (21). In our current study, we assessed the anti-TB activity of macrophages induced by ZXL1, which can be considered an additional antimycobacterial mechanism of the aptamer ZXL1.
